Attovia Therapeutics Funding & Investors
Fremont, CA
Attovia Therapeutics is a biotherapeutics pipeline developer focused on immune-mediated illness and oncology. The company uses the nanobody platform to create tiny format binders with low picomolar affinity, increased selectivity, quicker internalization, and rapid tissue penetration, thereby assisting cancer patients' treatment.
attovia.comTotal Amount Raised: $165,000,000
Attovia Therapeutics Funding Rounds
Series B
$105,000,000
Series B Investors
Goldman Sachs Asset ManagementCormorant Asset ManagementFrazier Life SciencesIllumina VenturesvenBio PartnersLogos CapitalEcoR1 CapitalNextech VenturesRedmile GroupMarshall WaceSeries A
$60,000,000
Series A Investors
Frazier Life SciencesIllumina VenturesvenBio Partners
Funding info provided by Diffbot.